These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
474 related articles for article (PubMed ID: 15485484)
1. Non-steroidal anti-inflammatory drugs (NSAIDs) in Alzheimer's disease: old and new mechanisms of action. Gasparini L; Ongini E; Wenk G J Neurochem; 2004 Nov; 91(3):521-36. PubMed ID: 15485484 [TBL] [Abstract][Full Text] [Related]
2. Novel therapeutic opportunities for Alzheimer's disease: focus on nonsteroidal anti-inflammatory drugs. Townsend KP; Praticò D FASEB J; 2005 Oct; 19(12):1592-601. PubMed ID: 16195368 [TBL] [Abstract][Full Text] [Related]
3. Non-steroidal anti-inflammatory drugs have anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro. Hirohata M; Ono K; Naiki H; Yamada M Neuropharmacology; 2005 Dec; 49(7):1088-99. PubMed ID: 16125740 [TBL] [Abstract][Full Text] [Related]
4. [Therapy of Alzheimer disease]. Kovács T Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816 [TBL] [Abstract][Full Text] [Related]
5. Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice. Heneka MT; Sastre M; Dumitrescu-Ozimek L; Hanke A; Dewachter I; Kuiperi C; O'Banion K; Klockgether T; Van Leuven F; Landreth GE Brain; 2005 Jun; 128(Pt 6):1442-53. PubMed ID: 15817521 [TBL] [Abstract][Full Text] [Related]
6. Activity of flurbiprofen and chemically related anti-inflammatory drugs in models of Alzheimer's disease. Gasparini L; Ongini E; Wilcock D; Morgan D Brain Res Brain Res Rev; 2005 Apr; 48(2):400-8. PubMed ID: 15850679 [TBL] [Abstract][Full Text] [Related]
7. Transgenic AD model mice, effects of potential anti-AD treatments on inflammation, and pathology. van Groen T; Miettinen P; Kadish I J Alzheimers Dis; 2011; 24(2):301-13. PubMed ID: 21239852 [TBL] [Abstract][Full Text] [Related]
8. Nuclear receptor peroxisome proliferator-activated receptor-gamma is activated in rat microglial cells by the anti-inflammatory drug HCT1026, a derivative of flurbiprofen. Bernardo A; Ajmone-Cat MA; Gasparini L; Ongini E; Minghetti L J Neurochem; 2005 Feb; 92(4):895-903. PubMed ID: 15686492 [TBL] [Abstract][Full Text] [Related]
9. NSAIDs: small molecules for prevention of Alzheimer's disease or precursors for future drug development? Weggen S; Rogers M; Eriksen J Trends Pharmacol Sci; 2007 Oct; 28(10):536-43. PubMed ID: 17900710 [TBL] [Abstract][Full Text] [Related]
10. Transgenic AD model mice, effects of potential anti-AD treatments on inflammation and pathology. van Groen T; Kadish I Brain Res Brain Res Rev; 2005 Apr; 48(2):370-8. PubMed ID: 15850676 [TBL] [Abstract][Full Text] [Related]
11. 1-(3',4'-Dichloro-2-fluoro[1,1'-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel gamma-secretase modulator, reduces brain beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease without causing peripheral toxicity. Imbimbo BP; Del Giudice E; Colavito D; D'Arrigo A; Dalle Carbonare M; Villetti G; Facchinetti F; Volta R; Pietrini V; Baroc MF; Serneels L; De Strooper B; Leon A J Pharmacol Exp Ther; 2007 Dec; 323(3):822-30. PubMed ID: 17895400 [TBL] [Abstract][Full Text] [Related]
12. Non-steroidal anti-inflammatory drugs protect amyloid beta protein-induced increase in the intracellular Cl- concentration in cultured rat hippocampal neurons. Iwata R; Kitagawa K; Zhang NY; Wu B; Inagaki C Neurosci Lett; 2004 Sep; 367(2):156-9. PubMed ID: 15331142 [TBL] [Abstract][Full Text] [Related]
13. An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease. Imbimbo BP Expert Opin Investig Drugs; 2009 Aug; 18(8):1147-68. PubMed ID: 19589092 [TBL] [Abstract][Full Text] [Related]
14. [The possible suppression of Alzheimer's disease by nonsteroidal anti-inflammatory drugs]. de Jong D; Jansen RW; Verbeek MM; Kremer HP Ned Tijdschr Geneeskd; 2002 Nov; 146(44):2074-8. PubMed ID: 12448960 [TBL] [Abstract][Full Text] [Related]
15. Ibuprofen modifies cognitive disease progression in an Alzheimer's mouse model. Van Dam D; Coen K; De Deyn PP J Psychopharmacol; 2010 Mar; 24(3):383-8. PubMed ID: 18957478 [TBL] [Abstract][Full Text] [Related]
16. A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Weggen S; Eriksen JL; Das P; Sagi SA; Wang R; Pietrzik CU; Findlay KA; Smith TE; Murphy MP; Bulter T; Kang DE; Marquez-Sterling N; Golde TE; Koo EH Nature; 2001 Nov; 414(6860):212-6. PubMed ID: 11700559 [TBL] [Abstract][Full Text] [Related]
17. Activation of 5-HT4 receptors inhibits secretion of beta-amyloid peptides and increases neuronal survival. Cho S; Hu Y Exp Neurol; 2007 Jan; 203(1):274-8. PubMed ID: 16978609 [TBL] [Abstract][Full Text] [Related]
18. Mefenamic acid shows neuroprotective effects and improves cognitive impairment in in vitro and in vivo Alzheimer's disease models. Joo Y; Kim HS; Woo RS; Park CH; Shin KY; Lee JP; Chang KA; Kim S; Suh YH Mol Pharmacol; 2006 Jan; 69(1):76-84. PubMed ID: 16223958 [TBL] [Abstract][Full Text] [Related]